| 1. |
Einhaupl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol, 2006, 13(6): 553-559.
|
| 2. |
Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke, 2004, 35(3): 664-670.
|
| 3. |
Bousser MG. Cerebral venous thrombosis: diagnosis and management. Journal of Neurology, 2000, 247(4): 252-258.
|
| 4. |
Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurology, 2007, 6(2): 162-170.
|
| 5. |
王建禎, 凌鋒, 吉訓明, 等. 老年人腦靜脈竇血栓形成26例臨床分析. 中國老年學雜志, 2007, 27(5): 876-877.
|
| 6. |
魏東寧, 陳玉萍. 中國人腦靜脈及靜脈竇血栓形成的臨床特點. 中國卒中雜志, 2007, 2(9): 729-733.
|
| 7. |
支興龍, 王建禎, 凌鋒, 等. 影響腦靜脈竇血栓預后的相關因素分析(附87例報告). 山東醫藥, 2007, 47(23): 77-78.
|
| 8. |
Canhão P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke, 2005, 36(8): 1720-1725.
|
| 9. |
Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet, 1991, 338(8767): 597-600.
|
| 10. |
De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke, 1999, 30(3): 484-488.
|
| 11. |
Ferro JM, Lopes MG, Rosas MJ, et al. Long-term prognosis of cerebral vein and dural sinus thrombosis. results of the VENOPORT study.Cerebrovascular Diseases (Basel, Switzerland), 2002, 13(4): 272-278.
|
| 12. |
Breteau G, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol, 2003, 250(1): 29-35.
|
